David Leverett
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Mesenchymal stem cell research
Papers in
-
- Hematopoietic Stem Cell Transplantation 3
- Oncology 3
- Neutropenia and Cancer Infections 2
- Co-authors
- Michael Watts (4 shared papers)David C. Linch (3 shared papers)Stuart J. Ings (3 shared papers)Stephen Mackinnon (1 shared paper)Stephen Devereux (3 shared papers)Anthony H. Goldstone (3 shared papers)D C Linch (2 shared papers)Amanda R. Perry (2 shared papers)
- Journals
- British Journal of Haematology (2 papers)Blood (2 papers)Vox Sanguinis (1 paper)Bone Marrow Transplantation (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
David Leverett
11 papers receiving 324 citations
Peers
Comparison fields: 5 of 40
- Hematology 216
- Genetics 50
- Transplantation 11
- Oncology 94
- Immunology 64
Countries citing papers authored by David Leverett
This map shows the geographic impact of David Leverett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Leverett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Leverett more than expected).
Fields of papers citing papers by David Leverett
This network shows the impact of papers produced by David Leverett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Leverett. The network helps show where David Leverett may publish in the future.
Co-authors
The 25 scholars most cited alongside David Leverett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 119 | |
| 2 | 1998 | 53 | |
| 3 | 2000 | 49 | |
| 4 | 1997 | 29 | |
| 5 | 2013 | 25 | |
| 6 | 2020 | 24 | |
| 7 | 2016 | 21 | |
| 8 | 1999 | 13 | |
| 9 | 2004 | 4 | |
| 10 | A comparison of ESHAP+G-CSF vs cyclophosphamide 1.5g/m(2)+G-CSF for PBSC mobilisation in pre-treated lymphoma patients: A matched pair analysis. | 1996 | 1 |
| 11 | 2020 | 1 |
About David Leverett
David Leverett is a scholar working on Hematology, Oncology, Immunology, Infectious Diseases and Pathology and Forensic Medicine, having authored 11 papers that have together received 339 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (3 papers), Complement system in diseases (3 papers), Lymphoma Diagnosis and Treatment (2 papers), COVID-19 Clinical Research Studies (2 papers), Blood disorders and treatments (2 papers), Neutropenia and Cancer Infections (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Hermeneutics and Narrative Identity (1 paper). The work is most often cited by research in Hematology (216 citations), Genetics (50 citations), Transplantation (11 citations), Oncology (94 citations) and Immunology (64 citations). David Leverett has collaborated with scholars based in United Kingdom. Frequent co-authors include Michael Watts, David C. Linch, Stuart J. Ings, Stephen Mackinnon, Stephen Devereux, Anthony H. Goldstone, D C Linch, Amanda R. Perry, Angela Sullivan and Marie Scully. Their work appears in journals such as British Journal of Haematology, Blood, Vox Sanguinis, Bone Marrow Transplantation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.